Drug intelligence / Profile preview

Eric diluent

Development stage: Preclinical
Modality: Hydrogel Systems → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

Eric diluent is a topical preparation used in a 1:20 dilution for the "postage stamp method" in the treatment of skin lesions, specifically for Pemphigus Vulgaris. While the general function of a diluent is to reduce the concentration or viscosity of another substance or to act as a filler, in this context, its direct application suggests it may possess cleansing, antiseptic, or wound-healing properties. However, its specific chemical composition and detailed mechanism of action are not provided in the available information.

Other names: 艾力克稀释液

Beyond the preview

Go deeper on Eric diluent.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eric diluent.

Explore the full profile